[go: up one dir, main page]

HK1001471B - 应用1-(2-萘乙基)-4-(3-三氟甲基苯基)-1,2,3,6-四氢吡啶制备治疗脑及神经疾病的药剂 - Google Patents

应用1-(2-萘乙基)-4-(3-三氟甲基苯基)-1,2,3,6-四氢吡啶制备治疗脑及神经疾病的药剂 Download PDF

Info

Publication number
HK1001471B
HK1001471B HK98100449.0A HK98100449A HK1001471B HK 1001471 B HK1001471 B HK 1001471B HK 98100449 A HK98100449 A HK 98100449A HK 1001471 B HK1001471 B HK 1001471B
Authority
HK
Hong Kong
Prior art keywords
use according
treatment
preparation
disorders
dementia
Prior art date
Application number
HK98100449.0A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1001471A1 (zh
Inventor
Xavier Coude Francois
Fournier Jacqueline
Guzzi Umberto
Original Assignee
赛诺菲 安万特
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9006399A external-priority patent/FR2662355B1/fr
Application filed by 赛诺菲 安万特 filed Critical 赛诺菲 安万特
Publication of HK1001471A1 publication Critical patent/HK1001471A1/zh
Publication of HK1001471B publication Critical patent/HK1001471B/zh

Links

HK98100449.0A 1990-05-22 1998-01-20 应用1-(2-萘乙基)-4-(3-三氟甲基苯基)-1,2,3,6-四氢吡啶制备治疗脑及神经疾病的药剂 HK1001471B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9006399 1990-05-22
FR9006399A FR2662355B1 (fr) 1990-05-22 1990-05-22 Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.

Publications (2)

Publication Number Publication Date
HK1001471A1 HK1001471A1 (zh) 1998-06-19
HK1001471B true HK1001471B (zh) 1998-06-19

Family

ID=

Similar Documents

Publication Publication Date Title
DE69115989T2 (de) Verwendung von 1-(2-Naphthylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridin zur Herstellung eines Medikaments zur Behandlung von zerebralen und neuronalen Krankheiten
US6232326B1 (en) Treatment for schizophrenia and other dopamine system dysfunctions
DE69331605T2 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
DE60209504T2 (de) Carbocyclische hydrazino-hemmer von kupferhaltigen aminoxidasen
DE69814688T2 (de) Benzylidene- und cinnamylidene-anabaseine als neuronale nikotin alpha-7 rezeptoragonisten
DE69532482T2 (de) Kombinationspräparat zur behandlung der parkinsonschen krankheit, das selektive nmda-antagonisten enthält
Hoerr et al. Ensaculin (KA‐672. HCl): A Multitransmitter Approach to Dementia Treatment
DE69629392T2 (de) Inhibitoren der aktivität der cyclophilin rotamase
DE69623899T2 (de) Behandlung von Tinnitus mit neuroprotektiven Wirkstoffen
US6583172B1 (en) Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders
DE69832688T2 (de) Hochselektive butyrylcholinesterase inhibitoren zur behandlung und zur diagnose von demenz und alzheimers krankheit
IE83649B1 (en) Use of a 1-(2-naphthylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6- tetra-hydropyridine for the manufacture of a medicament for the treatment of cerebral and neuronal diseases
DE69715862T2 (de) Verwendung eines k-252a derivats zur behandlung von periphärer oder zentraler nervenerkrankungen und übermässiger cytokinbildung
DE60125681T2 (de) Verwendung von NMDA NR2B Antagonist zur Behandlung von Depressionen.
Matsuoka et al. Differential effects of physostigmine and pilocarpine on the spatial memory deficits produced by two septo-hippocampal deafferentations in rats
US20060241144A1 (en) Method for treating apathy syndrome
Westfall et al. Regulation by nicotine of midbrain dopamine neurons
EP3849976B1 (en) A gaba a receptor ligand
US6436937B1 (en) Use of desoxypeganine in the treatment of Alzheimer's dementia
HK1001471B (zh) 应用1-(2-萘乙基)-4-(3-三氟甲基苯基)-1,2,3,6-四氢吡啶制备治疗脑及神经疾病的药剂
DE69814089T2 (de) Verwendung von einem draflazin analog zur schmerzbehandlung
ZA200106690B (en) Use of tianeptin in the production of medicaments to treat neurodegenerative pathologies.
MXPA00012248A (es) Incrementadores de acetilcolina.
WO2004002494A1 (en) Composition for preventing or treating degenerative brain diseases comprising a hydrolysate of ginsenosides
DE69432000T2 (de) Verwendung von Tetrahydropyridinderivaten zur Herstellung von Kardioprotektiven Medikamenten